Searched for
FDA RECOMMENDED LIMIT
Shopify to ban vapes as US authorities crack down on illegal e-cigarettes industryShopify is poised to ban all vape sales from its platform this week, responding to pressure from U.S. state attorneys general. This move ta...- Wockhardt shares rocket 19% after FDA approval for antibiotic targeting drug-resistant infections. Check detailsWockhardt's shares surged 19% after the U.S. FDA approved ZAYNICH, a novel intravenous antibiotic for complicated urinary tract infections....
- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Experts back OTC access to NRT across all formats and dosages, including 2 mg and 4 mg, as India struggles with a Tobacco quit success rate under 5%The report highlights the significant economic burden of tobacco use, particularly among low-income households, and underscores how reducin...
- Biocon's Bengaluru drug manufacturing facility gets 'Voluntary Action Indicated' classificationBiocon Biologics' drug substance facility in Bengaluru has been classified as Voluntary Action Indicated (VAI) by the USFDA. This classific...
- FDA approves updated COVID-19 shots but limits access for some kids and adultsU.S. regulators have approved updated COVID-19 shots from Pfizer, Moderna, and Novavax, but access is now limited for younger adults and ch...
- FDA panel debates COVID-19 vaccine recipe as questions swirl about fall shotsGovernment advisers are convening to discuss potential COVID-19 vaccine updates for the fall and winter, amidst a new policy that limits ro...
- Trump’s FDA just changed COVID vaccine rules for 2025 — will you still qualify for boosters under the new guidelines?FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and high-risk ind...
- New Trump vaccine policy might limit access to your future COVID shots: 10 pointsThe US Food and Drug Administration changes Covid-19 vaccine approval process. Access to seasonal boosters is restricted for healthy indivi...
- US to limit Covid-19 boosters to over-65s or those at high riskUS health officials announced a shift in Covid-19 booster policy, limiting routine doses to those over 65 or at high risk. New placebo-cont...
- Aurobindo Pharma, Glenmark recall products in USAurobindo, Glenmark, and Zydus are recalling pharmaceutical products in the US due to manufacturing issues. Aurobindo and Glenmark's recall...
- Heavy metal in most chocolates may not pose health risk, researchers saySome consumer groups and independent test agencies have previously reported heavy metal contamination in cocoa products such as dark chocol...
- Popular nasal decongestant Sudafed, Allegra, and Dayquil doesn't actually relieve congestionFDA advisers unanimously vote against phenylephrine's effectiveness in over-the-counter decongestants. Recent studies suggest it provides n...
- Gambia deaths: US FDA issues alertThe FDA said manufacturers must perform the DEG and EG limit test on representative samples of each shipment of each lot of the component a...
- CDSCO suspends manufacturing of eye drops linked to 55 adverse events in United StatesAccording to the people aware of the matter, the US-based Food and Drug Administration has warned the consumers "not to purchase or use Ezr...
- Joe Biden to let health experts decide who will get a Covid-19 vaccine first: Dr. Celine GounderSince the risk for COVID-19 can vary among different groups of people, prioritisation for a vaccine will be tricky, and Biden will leave th...
- FDA restricts anti-cholestrol drug heavy dosageThe US drug regulator has put restrictions on use of high dose of anti-cholesterol drug simvastatin with insignificant impact on Indian rev...
- Ranbaxy recalls drug in USRanbaxy Laboratories is voluntarily recalling a batch of its best-selling anti-acne drug remaining in the US market that was banned earlier...
- Ranbaxy recalls drugs for skin disease from US marketPharma major Ranbaxy Laboratories today said its US-based subsidiary, Ranbaxy Laboratories Inc Priceton NJ, is recalling capsules used in t...
- US regulator charges Ranbaxy of falsifying data, test resultsTo address falsified data, FDA has invoked its Application Integrity Policy (AIP) against Paonta Sahib facility. Factors for successful M&A...
Load More
